Page 5 - Revascularization Device News Today

H-CYTE (OTCMKTS:HCYTD – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Analyst Ratings This is a summary of recent ratings and […]

Modular Medical (OTC:MODD – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Earnings & Valuation This table compares Modular Medical and […]

Mainstay Capital Management LLC ADV acquired a new position in shares of Penumbra, Inc. (NYSE:PEN – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 960 shares of the company’s stock, valued at approximately $268,000. Other hedge funds have also recently […]

Cordatus Wealth Management LLC lowered its stake in Penumbra, Inc. (NYSE:PEN – Free Report) by 5.6% in the 1st quarter, HoldingsChannel.com reports. The fund owned 5,575 shares of the company’s stock after selling 329 shares during the quarter. Penumbra comprises 2.0% of Cordatus Wealth Management LLC’s investment portfolio, making the stock its 18th largest holding. […]

Cookson Peirce & Co. Inc. purchased a new position in Penumbra, Inc. (NYSE:PEN – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 730 shares of the company’s stock, valued at approximately $203,000. Other institutional investors and hedge funds also […]

Cwm LLC trimmed its stake in Penumbra, Inc. (NYSE:PEN – Free Report) by 9.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,680 shares of the company’s stock after selling 170 shares during the period. Cwm LLC’s holdings in Penumbra were worth $468,000 […]

Penumbra, Inc. (NYSE:PEN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target price among brokerages […]

Robert W. Baird initiated coverage on shares of Penumbra (NYSE:PEN – Free Report) in a report released on Tuesday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $375.00 price target on the stock. Other analysts also recently issued reports about the stock. Needham & Company LLC downgraded shares of Penumbra from a […]

Penumbra (NYSE:PEN – Free Report) had its target price upped by BTIG Research from $328.00 to $351.00 in a research report sent to investors on Monday, FlyOnTheWall reports. PEN has been the subject of several other reports. Deutsche Bank Aktiengesellschaft boosted their price target on Penumbra from $325.00 to $376.00 in a report on Monday, […]

F M Investments LLC purchased a new stake in Penumbra, Inc. (NYSE:PEN – Free Report) during the first quarter, according to its most recent filing with the SEC. The firm purchased 7,065 shares of the company’s stock, valued at approximately $1,969,000. Penumbra accounts for approximately 2.0% of F M Investments LLC’s portfolio, making the stock […]